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161 Abstract The endogenous lipid agent N-arachidonoylethanolamine
(anandamide), among other effects, has been shown to be involved
in nociceptive processing both in the central and peripheral
nervous systems. Anandamide is thought to be synthesised by
several enzymatic pathways both in a Ca2+-sensitive and
Ca2+-insensitive manner, and rat primary sensory neurons produce
anandamide. Here, we show for the first time, that cultured rat
primary sensory neurons express at least four of the five known
Ca2+-insensitive enzymes implicated in the synthesis of
anandamide, and that application of 1,2-dioleoyl-sn-glycero-
3-phosphoethanolamine-N-arachidonoyl, the common substrate of
the anandamide-synthesising pathways, results in anandamide
production which is not changed by the removal of extracellular
Ca2+. We also show that anandamide, which has been synthesised
in primary sensory neurons following the application of
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-arachidonoyl
induces transient receptor potential vanil loid type 1 ion channel-
mediated excitatory effect that is not inhibited by concomitant
activation of the cannabinoid type 1 receptor. Finally, we show that
sub-populations of transient receptor potential vanil loid type 1 ion
channel-expressing primary sensory neurons also express some of
the putative Ca2+-insensitive anandamide-synthesising enzymes.
Together, these findings indicate that anandamide synthesised by
primary sensory neuron via a Ca2+-insensitive manner has an
excitatory rather than an inhibitory role in primary sensory neurons
and that excitation is mediated predominantly through autocrine
signalling. Regulation of the activity of the Ca2+-insensitive
anandamide-synthesising enzymes in these neurons may be
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capable of regulating the activity of these cells, with potential
relevance to controll ing nociceptive processing in these neurons.
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15 Abstract The endogenous lipid agent N -arachidonoy-
16 lethanolamine (anandamide), among other effects, has been
17 shown to be involved in nociceptive processing both in the
18 central and peripheral nervous systems. Anandamide is
19 thought to be synthesised by several enzymatic pathways both
20 in a Ca2+-sensitive and Ca2+-insensitive manner, and rat pri-
21 mary sensory neurons produce anandamide. Here, we show
22 for the first time, that cultured rat primary sensory neurons
23 express at least four of the five known Ca2+-insensitive enzymes
24 implicated in the synthesis of anandamide, and that application
25 of 1,2-dioleoyl-sn -glycero-3-phosphoethanolamine-N -
26arachidonoyl, the common substrate of the anandamide-
27synthesising pathways, results in anandamide production which
28is not changed by the removal of extracellular Ca2+. We also
29show that anandamide, which has been synthesised in primary
30sensory neurons following the application of 1,2-dioleoyl-sn-
31glycero-3-phosphoethanolamine-N-arachidonoyl induces tran-
32sient receptor potential vanilloid type 1 ion channel-mediated
33excitatory effect that is not inhibited by concomitant activation
34of the cannabinoid type 1 receptor. Finally, we show that sub-
35populations of transient receptor potential vanilloid type 1 ion
36channel-expressing primary sensory neurons also express some
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37 of the putative Ca2+-insensitive anandamide-synthesising en-
38 zymes. Together, these findings indicate that anandamide
39 synthesised by primary sensory neuron via a Ca2+-insensitive
40 manner has an excitatory rather than an inhibitory role in pri-
41 mary sensory neurons and that excitation is mediated predom-
42 inantly through autocrine signalling. Regulation of the activity
43 of the Ca2+-insensitive anandamide-synthesising enzymes in
44 these neurons may be capable of regulating the activity of these
45 cells, with potential relevance to controlling nociceptive pro-
46 cessing in these neurons.
47 Keywords TRPV1 . CB1 . Nociceptive processing . Pain
48 Introduction
49 N-Arachidonoylethanolamine (anandamide) [7] is an endog-
50 enous lipid agent implicated in a variety of physiological
51 functions and pathological processes both within, and outside,
52 the nervous system [3, 21]. Although anandamide interacts
53 with a variety of proteins [15], the majority of its actions are
54 mediated via the cannabinoid type 1 (CB1) receptor and the
55 transient receptor potential vanilloid type 1 ion channel
56 (TRPV1) [6, 7, 9, 26, 51]. One of the most prominent func-
57 tions of anandamide resides in its TRPV1- and CB1 receptor-
58 mediated regulatory action in nociception in primary sensory
59 neurons (PSN) [9].
60 Several cell types in various tissues, including PSN, pro-
61 duce anandamide [5, 8, 10, 44, 45], the synthesis of which is
62 believed to occur either in a Ca2+-sensitive, or Ca2+-insensi-
63 tive manner [22, 23, 32, 36, 41, 43, 47, 48] and through
64 several enzymatic pathways (Fig. 1). The molecular identities
65 and biochemical activities of six enzymes implicated in the
66 synthesis of various N-acylethanolamines (NAEA) including
67 anandamide from corresponding N -acylphosphatidyl-etha-
68 nolamines (NAPE) have now been established (Fig. 1) [22,
69 23, 32, 36, 41, 43]. We have recently shown that one of these
70 six enzymes, N -acylphosphatidylethanolamine-selective
71 phospholipase D (NAPE-PLD; Fig. 1), which is the only
72 known Ca2+-sensitive enzyme involved in anandamide syn-
73 thesis [32, 43, 47, 48], is expressed by a sub-population of
74 PSN [29]. However, the ability of PSN to produce ananda-
75 mide in the absence of Ca2+ [45] indicates that, in addition to
76 the Ca2+-sensitive pathway (Fig. 1), one or more Ca2+-insen-
77 sitive pathways must also be present in these cells.
78 Anandamide synthesised in a Ca2+-sensitive manner in-
79 duces excitation of PSN through the activation of TRPV1
80 [44]. However, the effect of anandamide synthesised by
81 Ca2+-insensitive enzymes acting on NAPE in PSN is not
82 known. Therefore, after having first examined the expression
83 and function of putative Ca2+-insensitive NAPE-converting
84 enzymes, we also studied the effect of anandamide produced
85 by these enzymes, in cultured rat PSN.
86Materials and methods
87All experiments were performed in accordance with the UK
88Animals (Scientific Procedures) Act 1986, and the Directive
892010/63/EU of the European Parliament and of the Council on
90the Protection of Animals Used for Scientific Purposes. Every
91effort was taken to minimize the number of animals used.
92Altogether, seventy eight 80–120 g male Sprague–Dawley
93rats, five wild type (C57BL/6 x129SvJ; WT) and six
94TRPV1−/− mice (with C57BL/6 x129SvJ background; KO)
95were used.
96Drugs
97The following compounds were used: 1,2-dioleoyl-sn -
98glycero-3-phosphoethanolamine-N -arachidonoyl (20:4-
99NAPE; Avanti Polar, dissolved in 1:1 ethanol/Tocrisolve
100[Tocris]); capsaicin (Tocris; dissolved in dimethyl sulphoxide
101[DMSO], Sigma); capsazepine (Tocris; dissolved in DMSO);
102(5Z ,8Z ,11Z ,14Z )-5,8,11,14-eicosatetraenyl-methyl ester
103phosphonofluoridic acid (MAFP; Tocris, dissolved in
104DMSO); rimonabant (Cayman Chemicals, dissolved in
105DMSO), mustard oil (Sigma, dissolved in DMSO).
106Chloroform, in which 20:4-NAPE is delivered, was evap-
107orated in a N2 atmosphere. Dried 20:4-NAPE was stored at
108−80 °C and re-dissolved in ethanol (100 mM) on the day of
109the experiment and stored at −20 °C for a maximum of a
110month. The final stock solution (50 mM) of 20:4-NAPE was
111prepared by adding equal volume of Tocrisolve to the 100mM
11220:4 NAPE and vortexed. This final stock was used on the day
113of the preparation. The maximum final concentration of
Fig. 1 Putative anandamide-synthesising enzymatic pathways. A sche-
matic representation of the putative anandamide-synthesising enzymatic
pathways. The molecular identity of six enzymes has been established so
far (bold). While NAPE-PLD synthesises anandamide in a Ca2+-sensitive
manner, other enzymes (underlined), the expression of which has been
studied in these experiments, act in a Ca2+-insensitive manner. Substrates
are shown in italics . NAPE -PLD N -acylphosphatidylethanolamine
phospholipase D, GDE1 glycerophosphodiester phosphodiesterase 1,
ABHd4 α/β-hydrolase 4, PTPn22 protein tyrosine phosphatase, non-
receptor type 22, sPLAG1b group 1b soluble phospholipase A2, Inpp5
inositol 5′-phosphatase, NAPE N-acylphosphatidylethanolamine, PLC
phospholipase C
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114 Tocrisolve and ethanol were 0.05 %. The maximum final
115 concentration of DMSO was also 0.05 %.
116 Cultures of dorsal root ganglia
117 Dorsal root ganglion (DRG) cultures were prepared as de-
118 scribed [31]. Briefly, DRG from the first cervical to the sixth
119 lumbar segments were collected in Ham's nutrient F12 culture
120 medium (Sigma) supplemented with 2 % Ultroser G
121 (BioSepra SA), 1 mM glutamine (Invitrogen), 50 IU/ml pen-
122 icillin (Invitrogen) and 50 μg/ml streptomycin (Invitrogen).
123 Following incubation in 2,000 U/ml collagenase type IV
124 (Worthington Biochemical Corporation) for 3 h, DRG were
125 triturated and the cells were plated on poly-DL-ornithine
126 (Sigma)-coated glass coverslips. Cells were grown for 24–
127 48 h in the supplemented medium to which nerve growth
128 factor (NGF, 50 ng/ml; Promega), was added. For Ca2+-im-
129 aging experiments, after trituration, the cell suspension was
130 centrifuged through 15 % bovine serum albumin (Sigma) and
131 then also supplemented with 10 μM cytosine arabinoside
132 (Sigma).
133 Isolation of total RNA
134 The total RNAwas isolated using QIA shredder and RNeasy
135 Mini or RNeasy Plus Mini Kits (Qiagen), as described [31].
136 Reverse transcriptase polymerase chain reaction (RT-PCR)
137 Extracted RNA (1 μg) was reverse-transcribed using Super-
138 Script II cDNA synthesis reagents (Invitrogen). Primers
139 designed to amplify rat glycerophosphodiester phosphodies-
140 terase 1 (GDE1, NM_198779.1), α/β-hydrolase 4 (ABHd4,
141 NM_001108866.1), protein tyrosine phosphatase, non-
142 receptor type 22 (PTPn22, NM_001106460.1), group 1b se-
143 cretory phospholipase A2 (sPLA2G1b, NM_031585.1), ino-
144 sitol 5′-phosphatase (Inpp5, NM_019311.1) and the house-
145 keeping gene, glyceraldehyde-3-phosphate dehydrogenase
146 (GAPDH , NC_005103), were purchased from Eurofins. The
147 sequences of the primers, annealing temperatures and the
148 predicted product sizes are shown in Table 1.
149 The PCR reaction mixture contained cDNA, forward and
150 reverse primers, 1.5 mM MgCl2, 1× Green Go-Taq Reaction
151 buffer (Promega), 0.2 mM deoxynucleotide mix (Promega)
152 and 1.25 U Go-Taq DNA polymerase (Promega). The ampli-
153 fication reaction consisted of 30 cycles with 0.5 min of dena-
154 turation at 95 °C, 1 min annealing at the given temperatures
155 (Table 1), and followed by 1 min final extension at 72 °C in
156 a thermal cycler (Eppendorf-Mastercycler Personal;
157 Eppendorf). For GAPDH, the amplification reaction consisted
158 of only 25 cycles. PCR products were separated on 2 %
159 agarose gels by electrophoresis and visualized with ethidium
160 bromide.
161Immunofluorescence staining
162Cells attached to the coverslips were washed with PBS and
163fixed by 4 % paraformaldehyde in 0.1 M PBS (pH 7.4).
164Permeabilisation (0.3 % Triton-X 100), and blocking (10 %
165normal donkey serum) were followed by overnight incubation
166at 4 °C with primary antibodies at dilutions listed in Table 2,
167and visualisation with secondary antibodies. Coverslips were
168mounted on glass slides with Vectashield containing DAPI
169(Vector Laboratories) and examined using a Leica DMR
170Fluorescence microscope. Images were captured on a Hama-
171matsu CCD camera using the QWin software package (Leica).
172On some images the brightness and contrast were digitally
173modified. For control, the primary antisera were omitted, or
174the immunoreactions were performed on sections of tissues in
175which the expression of the various anandamide-synthesising
176enzymes had been shown previously. While no staining in
177PSN neurons was seen when the primary antibodies were
178omitted, enzyme expression was seen in various tissues with
179already demonstrated expression of the anandamide-
180synthesising enzymes (data not shown).
181Anandamide release
182Cultures were washed twice with HBSS–HEPES buffer (in
183mM: NaCl 111, KCl 3, MgCl2 0.49, CaCl2 1.27, glucose 5.5,
184MgSO4 0.4, KH2PO4 0.44, Na2HPO4 0.33, HEPES 10, 100
185nM MAFP, pH 7.4) then incubated for 5 min in HBSS–
186HEPES buffer or HBSS–HEPES buffer containing 20:4-
187NAPE (30 nM, 100 nM, 300 nM, 1 μM, 3 μM, 10 μM,
18830 μM, 100 μM). In some experiments, CaCl2 was omitted
189from, and 10 mM ethylene glycol tetraacetic acid (EGTA,
190Sigma) was added to the buffer. All the washes and incuba-
191tions were carried out at 37 °C unless stated otherwise.
192The superfusate was collected on ice and either processed
193immediately for lipid extraction or stored at −80 °C for further
194processing. Cells were immediately scraped into ice-cold cell-
195lysis buffer, used for protein quantification using BCA Protein
196Assay Reagent. For some anandamide measurements, only
19710 % of the cells were used for protein quantification. The
198remaining 90 % of the cells were stored in methanol, and then
199added to the buffer for anandamide measurements.
200Anandamide measurements
201The 20:4-NAPE application-induced anandamide synthesis was
202measured using three slightly different methods (Fig. S1). For
203protocol A (Fig. S1a), lipids were extracted from the buffer into
204ethyl acetate. Following evaporation of ethyl acetate, lipids were
205reconstituted in acetonitrile prior to quantification of ananda-
206mide by ultra-high performance liquid chromatography-
207electrospray-tandem mass spectrometry (UHPLC-ESI-MS/
208MS) using an Acquity UPLC BEH C18 (2.1×30 mm) column
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209 (Waters) with an Acquity UPLC BEH C18 VanGuard Pre col-
210 umn (Waters) maintained at 60°C and a Shimadzu Nexera
211 UHPLC (Shimadzu Scientific Instruments). Mobile phases
212 comprised A (water containing 0.1 % formic acid) and B
213 (acetonitrile containing 0.1 % formic acid) and the gradient
214 conditions were: 0 min, 2 % B; 1.8 min, 95 % B; 2.3 min,
215 95 % B, 2.31 min, 2 % B then re-equilibrated at 2 % B until
216 3.0 min. Samples were maintained at 4°C throughout. Analytes
217 were detected using tandem electrospray mass spectrometry in
218 positive ion mode (API 4000, ABSciex) and multiple reaction
219 monitoring with transitions ofm /z 348.5>62.0 andm/z 348.5>
220 91.052 for anandamide andm /z 260.420>116.200 for propran-
221 olol, used as internal standard (Fig. S1a). Anandamide
222concentrations were derived from the relative response against
223authentic standards using Analyst 1.5.1 (ABSciex). The thresh-
224old of quantitation was 0.01 nM.
225For protocol B (Fig. S1b), lipids were extracted from the
226superfusate using solid-phase extraction as described [19].
227Briefly, superfusates, buffers and cell-free controls were
228supplemented with octa-deuterated anandamide (Cayman
229Chemicals, 2.5 pmol/ml) and loaded onto a pre-conditioned
230Oasis HLB 1 cm3, 30 mg cartridge (Waters). Cartridges were
231washed with 40 % aqueous methanol and then eluted with
232acetonitrile (1 ml, Fisher Scientific). Eluants were dried under
233constant N2 stream and then re-suspended in acetonitrile
234(80 μl). Quantification of anandamide was done by UHPLC-
235ESI-MS/MS as described [25] using an Acquity UPLC BEH
236C18 (2.1×50 mm) column (Waters) maintained at 40 °C and an
237Acquity UHPLC system (Waters). Mobile phases comprised A
238(2 mM ammonium acetate containing 0.1 % formic acid and
2395 % acetonitrile) and B (acetonitrile containing 0.1 % formic
240acid) and the gradient conditions were as follows: 0–0.5 min,
24120%B; 2.5min, 100%B; 3.5min, 20%B then re-equilibrated
242at 20 % B until 4.0 min. Samples were maintained at 4 °C all
243throughout. Analytes were detected using tandem ESI-MS/MS
244in positive ion mode (Quattro Premier tandem mass spectrom-
245eter, Waters) and multiple reaction monitoring with transitions
246ofm /z 348.25>61.85 andm /z 356.4>63.0 for anandamide and
247deuterated anandamide internal standard, respectively
248(Fig. S1b). Anandamide concentrations were derived from the
249relative response against authentic standards using Quanlynx
250(Waters). The threshold of quantitation was 0.005 nM.
251Protocol C (Fig. S1c) was used in experiments in which the
252anandamide content of the superfusate and cells were measured
253together. Here, the samples were treated with 5 pmol octa-
254deuterated anandamide (Cayman Chemicals) in 1 vol. of
255chloroform/methanol (2:1 by vol.) and sonicated for 1 min in a
256sonication bath. The aqueous phase was then extracted twice
257with chloroform (1 vol.). The three, pooled organic phases were
258lyophilized and purified on silica mini columns as previously
259described [25]. The silica column fractions containing
t1:1 Table 1 Sequences, annealing
temperature and expected product
size of primers used for RT-PCR
t1:2 Primer Sequence Temperature (°C) Expected product size (bp)
t1:3 GDE1 F: TGCAGAAGGATTTTGTCTCC
R: TTGGGGTAAAACTGTGGCTA
57 298
t1:4 ABHd4 F: CAAAGCCATGATGGAGTCCT
R: GATCTCCTCCACCACAGCAT
57 244
t1:5 PTPn22 F: CATTGAAGACCCCAGGAAAA
R: CAAGTTGATGGTGGGTTCCT
61 202
t1:6 sPLA2G1b F:ACTGCTACAATCAGGCCAAG
R: GTGCGGTGCAGAAATAAGAC
57 292
t1:7 Inpp5 F: TACACACCTCTCACCCACCCA
R: GCTGGTGAGGTTCTTCAAGC
57 160
t1:8 GAPDH F: ACCCATCACCATCTTCCA
R: CATCACGCCACAGCTTTCC
57 380
t2:1 Table 2 List of primary and secondary antibodies used for
immunostaining
t2:2 Primary Antibodies
(supplier)
Dilution of
primary
antibodies
Secondary antibodies
and their dilutions
t2:3 GDE1 (Santa Cruz) 1:500 AF-568 donkey anti-rabbit
IgG (1:1,000)
t2:4 ABHd4 (Santa Cruz) 1:200 AF-568 donkey anti-goat
IgG (1:3,000)
t2:5 Inpp5 (Santa Cruz) 1:150 AF-568 donkey anti-mouse
IgG (1:1,000)
t2:6 PTPn22 (ProteinTech
Group)
1:500 AF-568 donkey anti-rabbit
IgG (1:1,000)
t2:7 sPLA2G1b (Millipore) 1:150 AF-568 donkey anti-mouse
IgG (1:1,000)
t2:8 NeuN (Millipore) 1:1,000 AF-488 donkey anti-mouse
IgG (1:1,000)
t2:9 TRPV1 (different
suppliersa)
1:2,000 AF-488 donkey anti-goat
IgG (1:10,000)
a Either guinea pig anti-TRPV1 antibody (Neuromics, Edina, MN, USA)
or rabbit anti-TRPV1antibody was used. The latter one was a kind gift
from Dr. Antonio Avelino (Institute of Histology and Embryology, Fac-
ulty of Medicine, University of Porto, Porto, Portugal) and tested inten-
sively including on dorsal root ganglia of TRPV1−/− mice
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260 anandamide were analysed by liquid chromatography-
261 atmospheric pressure-mass spectrometry (LC-APCI-MS)
262 conducted as described [25]. Analyses were carried out in the
263 selected ion-monitoring mode usingm /z values of 356 and 348
264 (molecular ions +1 for deuterated and undeuterated ananda-
265 mide), using a Shimadzu HPLC apparatus (LC-10ADVP;
266 Shimadzu Scientific Instruments) coupled to a Shimadzu
267 (LCMS-2020) quadrupole MS via a Shimadzu APCI interface
268 (Shimadzu Scientific Instruments; Fig. S1c). The threshold of
269 quantitation was 0.005 nM.
270 Cobalt uptake
271 Cobalt uptake was assessed as described [24, 34, 38, 39].
272 Briefly, cells attached to the coverslips were washed in a buffer
273 containing (in mM): NaCl 57.5, KCl 5, MgCl2 2, HEPES 10,
274 glucose 12, sucrose 139 (pH 7.4) then incubated in the presence
275 cobalt (5 mM) put into the buffer with or without 20:4-NAPE
276 (100 nM, 1 μM, 10 μM, 100 μM,) for 5 min at 37 °C. The
277 cobalt taken up by the cells was precipitated by 2.5 % β-
278 mercaptoethanol (Sigma). Cells were then fixed in 70 % etha-
279 nol and the coverslips were mounted on glass slides with
280 glycerol. The mean gray value of more than 100 cells which
281 were chosen randomly but systemically was established by a
282 Leica light microscope attached to a PC running the QWin
283 software package (Leica), and analysed with the ImageJ soft-
284 ware package (NIH, USA) as described [24, 34, 38, 39].
285 Whole-cell voltage-clamp recordings
286 An Axopatch 200B amplifier and a Digidata 1200 digitizer
287 (Molecular Devices, UK) were used to record whole-cell
288 currents from cultured PSN as described [31]. Borosilicate
289 glass micropipettes (4–6 MΩ) were pulled on a DMZ puller
290 (DMZ), and filled with the following solution (concentrations
291 in mM): NaCl 5, KCl 150, MgCl2 2, HEPES 10, EGTA 1;
292 pH 7.4. The extracellular buffer contained (in mM): NaCl 150,
293 KCl 5, MgCl2 2, CaCl2 2, HEPES 10, glucose 10; pH 7.4. All
294 recordings were done at 37 °C and collected with the pClamp
295 8 software package (Molecular Devices) with 1 kHz sampling
296 rate and 5 kHz filtering. The holding potential was −60 mV.
297 Recordings were analysed offline by the ClampFit 8.0 soft-
298 ware package (Molecular Devices).
299 Ca2+ imaging
300 Cells were loaded with Fura-2 acetoxymethyl ester (Fura-2
301 AM, 5 μM; Molecular Probes) in the presence of 2 mM
302 probenecid (Molecular Probes) for 60 min at 37 °C in a
303 HEPES-buffered saline (in mM): NaCl, 122; KCl, 3.3; CaCl2,
304 1.3; MgSO4, 0.4; KH2PO4 1.2; HEPES, 25; glucose, 10;
305 adjusted with NaOH to pH 7.3. Coverslips were superfused
306 with extracellular solution (in mM: NaCl, 160; KCl, 2.5;
307CaCl2, 1; MgCl2, 2; HEPES, 10; glucose, 10; pH 7.3) in a
308laminar flow perfusion chamber (Warner Instrument Corpo-
309ration). The following test solutions were applied subsequent-
310ly: 20:4-NAPE (50 μM), capsaicin (1 μM) and KCl (50 mM)
311(timing is indicated in the corresponding figures). For study-
312ing the involvement of TRPV1 or the CB1 receptor in the
31320:4-NAPE-evoked responses, either capsazepine (5 μM), or
314rimonabant (200 nM) was used to inhibit TRPV1 or the CB1
315receptor, respectively. The antagonists were applied for 60 s
316prior the application of 20:4-NAPE together with capsazepine
317or rimonabant. For control purposes, following the application
318of 20:4-NAPE together with capsazepine or rimonabant, the
319antagonists were not removed from the bath and capsaicin
320with capsazepine or rimonabant was applied. Only KCl-
321sensitive cells (neurons) were involved in subsequent analy-
322ses. At the end of some experiments, mustard oil (50 μM;
323Sigma) or/and ionomycin (5 μM, Sigma) was also applied.
324Application of drugs was controlled manually with one visual
325field being tested per coverslip. Experiments were performed
326at 37 °C, except where otherwise indicated.
327Images were captured with a Peltier element-cooled slow
328scan charge-coupled camera system (PTI). Following subtrac-
329tion of the background fluorescence, the ratio of fluorescence
330intensity at the two wavelengths as a function of time (rate 1
331Hz) was automatically calculated (R = F340/F380) and the
332resultant graphs analysed using the ImageMaster 5.0 software
333package (PTI) and the Microsoft Excel software package.
334Only recordings with a stable baseline before 20:4-NAPE
335application were included in the analyses. First, the noise
336and baseline before the first drug application were established.
337Then, the maximum amplitude of the 340/380 ratio was
338established in defined sections of recordings. Each of these
339defined sections started at the beginning of a drug application
340and lasted until the beginning of the next drug application. An
341increase of more than 10% in the 340/380 ratio was then
342regarded as a response, if, during visual verification, the
343change was clearly associated with the drug application.
344Based on our pilot data, 2.5 times of the standard deviation
345of the amplitude of the baseline noise equals with a maximum
346of 9.5–10 % increase in the 340/380 ratio.
347Statistics
348Data of repeated measurements were averaged. Differences
349between the averaged values were analysed by Student's t-test,
350one-way analysis of variance (ANOVA) or repeated measure
351multivariate ANOVA as appropriate. In ANOVA, following
352checking the normality of data, post hoc analysis for the statis-
353tically significant differences among the treatment groups was
354performed by the Fischer's test. Significant differences in the
355proportion of neurons responding to various drugs were
356assessed by Fisher's exact test. Data are shown as tmean ±
357standard error of mean. A difference between two values was
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358 considered to be significant if p <0.05. The n values refer to the
359 number of repeated experiments (number of cultures used for
360 immunohistochemistry, anandamide release measurements and
361 cobalt uptake, and the number of cells measured in whole-cell
362 recordings and calcium imaging) and p values are given as
363 <0.0001 if the actual value was smaller than that.
364 Results
365 Several Ca2+-insensitive enzymes, which are implicated
366 in anandamide synthesis, are expressed in rat cultured primary
367 sensory neurons
368 RT-PCR analysis showed gene expression for all five Ca2+-
369 insensitive enzymes that are known to be implicated in the
370 synthesis of NAEA, including anandamide, from the corre-
371 sponding NAPEs in cultures prepared from rat DRG (Figs. 1
372 and 2a). In order to study the expression of the enzymes at a
373 cellular level, immunostaining was performed on cultured rat
374 PSN using antibodies raised against the enzymes together with
375 an anti-NeuN-antibody, which identifies neurons. By analysing
376 the staining in at least 100 neurons in each culture, we found
377 that sub-populations of PSN express ABHd4, GDE1, Inpp5,
378 and PTPn22 (Fig. 2b; for the proportions of cells expressing
379 these enzymes please see Table 3). The analysis also revealed
380 that while only neurons express ABHd4, Inpp5 and PTPn22,
381 neurons and some non-neuronal cells express GDE1 (Fig. 2b).
382 The antibody raised against sPLA2G1b did not produce
383 staining in the cultures. However, the same antibody produced
384 staining in the pancreas (data not shown). The anti-ABHd4-,
385 anti-Inpp5-, anti-PTPn22- and anti-GDE1 antibodies also pro-
386 duced staining in tissues in which the expression of these
387 enzymes have been reported previously (data not shown).
388 When the primary antibodies were replaced with normal
389 serum, no staining was seen either in cultured PSN or in any
390 tissues which we processed (data not shown).
391 Application of 20:4-NAPE induces anandamide production
392 in cultured PSN
393 20:4-NAPE is the substrate for anandamide synthesis used by
394 all the known enzymatic pathways (Fig. 1) [20, 22, 23, 32, 36,
395 37, 41, 43]. Therefore, to ascertain whether the enzymes found
396 to be expressed in cultured rat PSN form any functional
397 anandamide-synthesising pathways, the level of 20:4-NAPE
398 application-induced anandamide synthesis was measured.
399 Exposure of the cells to 100 μM 20:4-NAPE significantly
400 increased the anandamide content of the buffer from a level
401 below the quantitation threshold in the control to 8.86±3.44
402 pmol/ml (n =4; Student's t-test, p =0.01; Protocol B) at 37°C.
403 After normalisation to the protein content, the anandamide
404 concentration was 13.25±4.39 ng/mg protein (n =4; Fig. 3a).
405Incubation of the cells in the vehicle resulted in an anandamide
406content of 0.01±0.01 ng/mg (n =3) protein in the superfusate
407(data not shown). This value was not significantly different
408from that measured in the control of this experiment (0.04±
4090.04 ng/mg protein, n =3; p =0.5, Student's t-test). Incubation
Fig. 2 Expression of enzymes implicated in Ca2+-insensitive anandamide
synthesis in cultured rat primary sensory neurons. a Representative gel
images of reverse transcriptase polymerase chain reaction products. The
products synthesised by specific primers to cDNA prepared by reverse
transcribing the total RNA isolated from cultured PSN.While mRNA of all
the five knownCa2+-insensitive enzymes are expressed in rat cultured PSN,
the level of their expression varies; GDE1 shows the highest level of
expression (please see also Fig. S2), while PTPn22 shows the lowest level
of expression. L indicates ladder. The predicted size of the PCR products is
shown in Table 1.b Representative images of cultured PSN immunostained
with antibodies raised against the putative Ca2+-insensitive anandamide-
synthesising enzymes with known molecular identity (red) in combination
with an antibody which selectively and specifically recognises neurons
(NeuN; green). The mounting medium contains DAPI (blue). The anti-
ABHd4, anti-GDE1, anti-Inpp5 and anti-PTPn22 antibodies produce stain-
ing in various sub-populations of cells. The anti-sPLA2G1b antibody does
not produce staining. The anti-GDE1 antibody, in addition to neurons, also
stains some non-neuronal cells (arrow). Quantitative analysis of the immu-
nostaining is shown in Table 3. Bars=25 μm
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410 of the cells in 100 μM 20:4-NAPE at room temperature also
411 significantly increased the anandamide concentration in the
412 buffer (from 0.06±0.03 ng/mg protein to 1.17±0.03 ng/mg
413 protein, n =3; Student's t-test, p =0.009; Fig. 3b). However,
414 the 20:4-NAPE application-induced increase in the anandamide
415 content of the buffer at room temperature was significantly less
416 than that measured at 37°C (Student's t-test, p =0.03) indicating
417 that the production of anandamide depends on enzyme activity.
418 To make sure that no 20:4-NAPE hydrolysing activity in the
419 buffer contributed to the increase in the anandamide levels, we
420 also quantified the anandamide content of cell-free superfusate
421 containing 100 μM 20:4-NAPE. The buffer was kept either at
422 room temperature or 37°C up to 4 h. We measured the lowest
423and highest anandamide concentration at 2.5 h at 37°C (0.023
424ng/ml) and at 5 min at 37°C (0.15 ng/ml), respectively. We
425found no apparent relationship between the anandamide con-
426tent and the time or temperature of incubation (data not shown).
427These data indicated that cultured rat PSN has the ability to
428convert 20:4-NAPE into anandamide.
429The 20:4-NAPE application-evoked increase in the
430anandamide content of the supernatant at 37°C was
431concentration-dependent (Fig. 3c; Protocol A). The lowest
43220:4-NAPE concentration at which the anandamide content
433of the superfusate was significantly different from that of
434the control was 10 μM (ANOVA followed by Fisher's
435test, p =0.03).
t3:1 Table 3 Relative number of cultured rat primary sensory neurons exhibiting immunopositivity for various enzymes, which are implicated in Ca2+-
insensitive anandamide synthesis, and for TRPV1
t3:2 ABHd4 GDE1 Inpp5 PTPn22 sPLA2G1b
t3:3 Relative number of cells exhibiting immunopositivity 29.8±1.9
n=3
40.27±9.94
n =3
44.1±1.9
n=3
48.53±10.04
n =3
n. d.
t3:4 Relative number of TRPV1-expressing cells 50.63±3.84
n=3
46.6±3.46
n =3
56.2±4.77
n=3
42.4±2.37
n =3
n. q.
t3:5 Relative number of TRPV1-expressing neurons which also exhibit
enzyme-immunopositivity
23.11±8.55
n=3
25.9±2.68
n =3
64.93±10.9
n=3
17.93±7.58
n =3
n. d.
t3:6 Relative number of enzyme-expressing neurons which also express TRPV1 13.25±4.5
n=3
21.8±4.21
n =3
51.27±8.33
n=3
16.4±5.49
n =3
n. d
n number of cultures, n .q . not quantified, n .d . not detected
Fig. 3 20:4-NAPE application induces anandamide production in cul-
tured rat primary sensory neurons. a Incubation of rat cultured PSN in the
presence of 100 μM20:4-NAPE for 5 min at 37 °C results in a significant
increase in the anandamide content of the superfusate when compared to
the basal anandamide level. The measurement was done by ultra-high
performance liquid chromatography-electrospray-tandem mass spec-
trometry following the extraction of lipids from the superfusate. Spectro-
grams of anandamide analysis are shown in Fig. S1. (n =4, asterisk
indicates significant difference.) b Incubation of rat cultured PSN in the
presence of 100 μM 20:4-NAPE for 5 min at room temperature also
increases the anandamide content of the superfusate. However, the anan-
damide content following incubation of the neurons at room temperature
is significantly smaller than following incubation of the neurons at 37 °C
(please note the difference in the scale of the y -axis in a and b ).
Spectrograms of anandamide analysis are shown in Fig. S1. (n =3,
asterisk indicates significant difference from the basal anandamide level
measured at room temperature.) c Incubation of rat cultured PSN in 30
nM–100 μM 20:4-NAPE for 5 min at 37 °C results in a concentration-
dependent increase in the anandamide content of the superfusate. The
lowest 20:4-NAPE concentration that induces significant increase of the
anandamide content of the superfusate is 10μM. (n =3 for each data point,
* indicates significant difference.) (D) Withdrawal of Ca2+ from the
superfusate does not change either the basal anandamide content of the
superfusate or the anandamide content of the superfusate following the
addition of 100 μM 20:4-NAPE for 5 min (n =3 for each data point,
asterisk indicates significant difference)
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436 Among the known anandamide-synthesising enzymes,
437 NAPE-PLD activity is significantly enhanced in the pres-
438 ence of Ca2+ [32, 42, 43, 47, 48]. To ascertain whether or
439 not during 20:4-NAPE application, any Ca2+ influx in-
440 creases the intracellular Ca2+ concentration [Ca2+]i to an
441 extent which is enough to contribute NAPE-PLD to anan-
442 damide synthesis, we applied 20:4-NAPE to cultured PSN
443 either with Ca2+ present or absent in the buffer. In the
444 presence of Ca2+, the anandamide content of the
445 superfusate of cells incubated with vehicle was 0.62±
446 0.35 ng/mg protein (n =3), whereas in the absence of
447 Ca2+, it was 0.98±0.12 ng/mg protein (n =3; Protocol
448 A). These values did not differ significantly from each
449 other (Student's t -test, p =0.4; Fig. 3d). Application of
450 20:4-NAPE (100 μM) resulted in a significant increase
451 in the anandamide content of the superfusate in both the
452 presence and absence of Ca2+ (9.57±2.58 ng/mg protein
453 (n =3) and 11.47±0.92 ng/mg protein (n =3); Student's t -
454 test, p =0.01 in the presence and p =0.0001 in the absence
455 of Ca2+; Fig. 3d). Thus, the anandamide content of the
456 Ca2+-containing, and Ca2+-free, superfusates did not differ
457 significantly from each other after the application of this
458 substrate (Student's t -test, p =0.5).
459 We also compared the anandamide content of the
460 superfusate to that of 90 % of the cells together with the
461 superfusate (the other 10 % of the cells was used for protein
462 measurements). The anandamide content of the cells and
463 superfusate together under control conditions (incubation with
464 vehicle) was 0.09 ng/mg protein (n =2; Protocol C). Follow-
465 ing 100 μM 20:4-NAPE application for 5 min, the ananda-
466 mide content of the cells and superfusate increased to
467 28.03 ng/mg protein (n =2; data not shown).
468 Together, these data indicate that the 20:4-NAPE application-
469 evoked anandamide synthesis in cultured rat PSN is not affect-
470 ed by the removal of Ca2+ from the extracellular buffer. These
471 data also show that about 2/3 of anandamide produced in PSN
472 following 20:4-NAPE application, similar to anandamide pro-
473 duced by increasing the [Ca2+]i in central neurons [8], is
474 retained in the cells.
475 20:4-NAPE application induces cobalt influx
476 into a sub-population of cultured rat PSN
477 Anandamide synthesised in PSN by increasing the [Ca2+]i
478 induces TRPV1-mediated excitation [44]. TRPV1 activa-
479 tion by anandamide results in cobalt accumulation in a
480 sub-population of PSN [24, 34, 38, 39]. Therefore, to test
481 whether endogenous anandamide synthesised following the
482 application of 20:4-NAPE has similar effect to that
483 synthesised in a Ca2+-sensitive manner, we studied cobalt
484 accumulation during 20:4-NAPE application. The efficacy
485 of this technique for assessing TRPV1-activity has been
486 consistently demonstrated [24, 30, 34, 38, 39, 49, 50].
487While application of the vehicle did not (2.63±
4880.34%, n =3; p =0.44, ANOVA followed by Fisher's
489test), application of 20:4-NAPE significantly increased
490the proportion of labelled neurons and this effect was
491concentration-dependent (Fig. 4a–c). The lowest concen-
492tration of 20:4-NAPE which produced a significant in-
493crease in the proportion of labelled cells was 0.1 μM
494(6.44±1.16 %, n =4 cultures; ANOVA followed by
495Fisher's test, p =0.01; Fig. 4c). The EC50 of 20:4-NAPE
496was 7.41±1.4 μM. The majority of the cobalt-labelled cells
497were small diameter neurons (Fig. 4d). These observations
498suggest that the cobalt influx occurred in nociceptive neurons,
499the great majority of which express TRPV1 [6, 31].
50020:4-NAPE application induces inward currents
501in a sub-population of cultured rat PSN
502To confirm the excitatory effect of 20:4-NAPE applica-
503tion, we recorded whole cell currents from cultured rat
504PSN. In total, 22 cells were found that responded with
505inward currents to 50 μM 20:4-NAPE which is the near
506maximal concentration for this agent to induce cobalt
507uptake (Fig. 5a). The peak amplitude of the response
508was −0.41±0.06 nA (n =22).
509All nine of the 20:4-NAPE-responsive neurons that we
510tested also responded to 500 nM capsaicin (Fig. 5a and b).
511The average amplitude of the 20:4-NAPE-evoked currents
512(−0.35±0.08 nA, n =9) was significantly smaller than that
513of the capsaicin-evoked currents (−2.36±0.55, n =9; Stu-
514dent's t-test, p =0.002; Fig. 5c). However, in addition to the
515double-responsive cells, 27 neurons which responded to
516capsaicin but not to 20:4-NAPE application were also
517found (data not shown). In the control experiments, no
518neurons produced any noticible responses to the vehicle
519(n =11, data not shown).
52020:4-NAPE application increases the [Ca2+]i in a capsazepine-
521and rimonabant-sensitive manner
522In order to study the pharmacological properties of the 20:4-
523NAPE application-evoked excitatory responses, we assessed
524changes in [Ca2+]i produced by the application of 50μM20:4-
525NAPE. Application of the vehicle for a minute did not pro-
526duce any increase in the [Ca2+]i in any of the 384 KCl-
527responding neurons, whereas 234 of these 384 responded to
5281 μM capsaicin application (data not shown). Application of
52920:4-NAPE, however, increased [Ca2+]i in 189 of 546 KCl-
530responding neurons (34.6 %; Fig. 6a and b). All the neurons
531that responded to 20:4-NAPE application were sensitive to
532capsaicin (Fig. 6a and b). In addition to the double-responsive
533neurons, 273 of the 546 neurons (50 %) responded only to
534capsaicin (Fig. 6a and b). Hence, the total number of
535capsaicin-responsive neurons was 462 of 546 (84.6 %;
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536 Fig. 6b), which was significantly higher than the proportion of
537 capsaicin-sensitive neurons measured when only the vechicle
538 (p <0.0001; Fischer's exact test) or the buffer (224 of
539 343 cells) was applied before capsaicin application. The
540 20:4-NAPE application-evoked changes in [Ca2+]i acti-
541 vated more slowly than those evoked by capsaicin
542 (Fig. 6a). Furthermore, the amplitude of the 20:4-NAPE
543 application-evoked responses were significantly smaller
544 than those evoked by capsaicin when normalised to the
545 KCl-evoked responses (20:4-NAPE/KCl=0.15±0.01, n =
546 189; capsaicin/KCl=0.78±0.02, n =462; Student's t -test,
547 p <0.0001; Fig. 6a). Interestingly, the great majority of
548 neurons, which generated responses to 20:4-NAPE ap-
549 plication, exhibited sustained/very slowly inactivating
550 Ca2+ transients to capsaicin application. On the other
551 hand, the great majority of capsaicin-responsive neu-
552 rons, which did not respond to 20:4-NAPE application,
553 exhibited fast inactivation of responses during capsaicin
554 application (Fig. 6a).
555 In the presence of capsazepine (5 μM), 403 KCl-
556 responding neurons exhibited a stable baseline before
557 20:4-NAPE application. Of these, 26 responded to
558 20:4-NAPE and capsaicin (6.45 %; Fig. 6b). In addition
559to these neurons, 16 cells responded only to 20:4-NAPE
560application, and 21 cells responded only to capsaicin.
561Thus, the overall proportions of both the 20:4-NAPE-
562(42 of 403, 10.4 %) and capsaicin-responding neurons
563(47 of 403, 11.7 %) in the presence of capsazepine were
564significantly smaller than that measured in the absence
565of capsazepine (Fisher's exact test, p <0.0001 for both
56620:4-NAPE and capsaicin; Fig. 6b).
567In the presence of rimonabant, 20:4-NAPE application in-
568creased [Ca2+]i in 105 of 498 KCl-responding neurons with a
569stable base line before 20:4-NAPE application (21.08 %;
570Fig. 6b). This proportion was significantly smaller from that
571measured in the control (Fisher's exact test; p <0.0001).
572Rimonabant, however, had no significant effect on the overall
573number of capsaicin-responding neurons (421 of 498 cells,
57484.54 %, p=1, Fisher's exact test; Fig. 6b). Rimonabant signif-
575icantly reduced the amplitude of both the 20:4-NAPE
576application-evoked (to 20:4-NAPE/KCl=0.12±0.009, Student's
577t-test, p =0.02), and the amplitude of the capsaicin-induced
578responses (to capsaicin/KCl=0.61±0.018, Student's t-test,
579p <0.0001). These data suggest that the 20:4-NAPE
580application-evoked excitatory effect is mediated by TRPV1,
581and that 20:4-NAPE application, when assessed average
Fig. 4 20:4-NAPE application induces cobalt uptake in a sub-population
of cultured rat primary sensory neurons. Representative images of cul-
tured rat PSN following the incubation of cells in a 5-mM CoCl2-con-
taining buffer for 5 min without (a) or with 20:4-NAPE (100 μM) (b).
The accumulated cobalt in the cells was precipitated by 2.5 % β-
mercaptoethanol. The images are inverted hence labelled cells appear as
bright cells which are indicated by arrows.When no 20:4-NAPE is added
to the CoCl2-containing buffer very few cells, if any at all, accumulate
cobalt (a). However, when 20:4-NAPE is added, a significant number of
neurons accumulate Co2+ (b). c Incubation of cultured rat PSN in a
CoCl2-containing buffer in the presence of 20:4-NAPE (100 nM-100
μM) for 5 min results in a concentration-dependent increase in the
number of cobalt-labelled cells. (n =3–9 for various data points, asterisk
indicates significant difference.) d The overwhelming majority of neu-
rons labelled by 20:4-NAPE application-induced cobalt influx (black
bars) are small diameter neurons. Empty bars depict non-labelled cells
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582 responses, does not result in a CB1 receptor mediated
583 inhibitory effect.
584 The 20:4-NAPE application-evoked increase in [Ca2+]i
585 in mouse PSN is mediated by TRPV1
586 In order to confirm the role of TRPV1 in 20:4-NAPE
587 application-evoked responses, we also studied the effect of
588 this agent on PSN isolated from WT and TRPV1−/− (KO)
589 mice. Ten of 68 KCl-responsive neurons (14.71 %) from
590 WT mice were regarded as responsive to 20:4-NAPE
591 (50 μM) application (Fig. 7a). As in experiments using rat
592 PSN cultures, all the 20:4-NAPE-responsive neurons were
593 responsive to capsaicin (1 μM; Fig. 7a) and the 20:4-NAPE
594 application-evoked responses activated more slowly than the
595 capsaicin-evoked responses (Fig. 7a). As with cultures pre-
596 pared from rat DRG, cultures prepared fromWTmouse DRG
597 also had neurons, which responded only to capsaicin (32 of 68
598 [48.53 %]; Fig. 7a).
599 In contrast, none of the KCl-responsive neurons (n =59)
600 responded to 20:4-NAPE application in cultures prepared from
601 DRG of KO mice (Fig. 7b). As expected, none of the neurons
602 in the cultures prepared from DRG of KO mice responded to
603capsaicin (Fig. 7b). However, 22 of the 59 KCl-responding
604cells responded to mustard oil, showing that the cells were
605healthy and responsive to agents for which they expressed
606receptors (Fig. 7b). Therefore, our findings on neurons of
Fig. 6 20:4-NAPE application induces increase in [Ca2+]i in a sub-
population of cultured rat primary sensory neurons, which is significantly
reduced by the inhibition of both the transient receptor potential vanilloid
type 1 ion channel and the cannabinoid 1 receptor. a Representative
recordings of changes in [Ca2+]i in cultured rat PSN superfused by
20:4-NAPE (50 μM) (a), capsaicin (1 μM) (b) and KCl (50 mM) (c)
as indicated. A proportion of neurons responds to 60-s application of
50 μM 20:4-NAPE (a) by a slow increase in [Ca2+]i (purple trace). All
the 20:4-NAPE-responding neurons also respond to 1 μM capsaicin (b)
application (purple trace). However, not all capsaicin-sensitive neurons
(red trace) respond to 20:4-NAPE application. b The bar chart shows
the proportion of neurons responding to various activators in the absence
or presence of the transient receptor potential vanilloid type 1 ion channel
antagonist capsazepine (5 μM) or the cannabinoid 1 receptor antagonist
rimonabant (200 nM). Both capsazepine and rimonabant significantly
reduces the proportion of the 20:4-NAPE-responding cells
Fig. 5 20:4-NAPE application
induces inward currents in a
sub-population of cultured rat
primary sensory neurons. a A
typical current trace recorded from
a PSN during the application of
20:4-NAPE (50 μM) for 60 s.
Bar above recording indicates
20:4-NAPE application. b The
neuron shown in a also responds
to 500 nM capsaicin. Bar above
recording indicates capsaicin
application. Note the difference in
the kinetics of the 20:4-NAPE- and
capsaicin-induced currents. c
Application of capsaicin (C) (500
nM) induces a significantly greater
current then application of 50 μM
20:4-NAPE (N). (n=9 for each
data point, asterisk indicates
significant difference)
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607 TRPV1−/− mice confirm that the 20:4-NAPE application-
608 evoked excitatory effects are mediated through TRPV1.
609 Sub-populations of cultured rat primary sensory neurons
610 co-express TRPV1 and enzymes implicated
611 in Ca2+-insensitive anandamide syntheses
612 The concentration of anandamide found in the superfusate
613 (~10 nM) is significantly lower than the concentration of
614 exogenous anandamide needed to induce TRPV1-mediated
615 excitatory effects [1, 12, 14, 38, 51]. Therefore, we
616 hypothesised that the excitatory effect of anandamide of
617 PSN origin is mediated through autocrine signalling. To find
618 out whether there is an anatomical basis for such autocrine
619 signalling, we used combined immunostaining for studying
620 the co-expression of TRPV1 with the Ca2+-insensitive
621 anandamide-synthesising enzymes. Analysis of this double
622 immunofluorescent staining showed that a significant propor-
623 tion of cultured rat PSN exhibit co-expression for TRPV1 and
624 the putative Ca2+-insensitive anandamide-synthesising en-
625 zymes (Fig. 8, Table 3).
626Discussion
627We have shown in the present study that four of the five
628enzymes (ABHd4, GDE1, Inpp5 and PTPn22) which have
629been implicated previously in Ca2+-insensitive anandamide
630synthesis from 20:4-NAPE [22, 23, 32, 36, 41, 43], are found
631at transcript level (please see also Fig. S2) in cultures prepared
632from rat DRG, and at protein level in cultured rat (and mouse,
633see Fig. S3) PSN. The GDE1 protein is also expressed by non-
634neuronal cells as well as by PSN. The anti-sPLA2G1b anti-
635body, which we used in this study, does not produce any
636staining in rat PSN cultures, although it labels cells in acini
637in the pancreas. RT-PCR shows weak expression of
638sPLA2G1b mRNA in PSN cultures. Hence, one cannot ex-
639clude the possibility that this enzyme may be expressed under
640the detection threshold of the immunostaining technique in
641some neurons or non-neuronal cells.
64220:4-NAPE application to PSN cultures increases the anan-
643damide concentration in the cells and the superfusate. The
644finding that application of 20:4-NAPE to cell-free superfusate
645does not increase the anandamide content of the buffer, to-
646gether with the finding that the anandamide content of the
647cells and superfusate is greater than that of the superfusate
648alone indicates that 20:4-NAPE passes the cells membrane
649and anandamide is synthesised intracellularly. Indeed, all
650NAPE-converting enzymes are intracellular and transiently
651associated with membranes to act on NAPEs embedded in
652those [4, 22, 23, 32, 36, 41, 43]. Therefore, the conversion of
65320:4-NAPE to anandamide in an enzymatic way, as we have
654shown here, can be only through the rapid incorporation of
655this phospholipid into the membranes and its hydrolysis by
656some of the enzymes we investigated here. The rate of anan-
657damide production induced by 100 μM 20:4-NAPE
Fig. 7 20:4-NAPE induces Ca2+ influx into cultured primary sensory
neurons isolated fromwild typemice but not into those which are isolated
from TRPV1−/− mice. (a and b) Representative recordings of changes in
[Ca2+]i in cultured mouse PSN superfused by 20:4-NAPE (50 μM) (a),
capsaicin (1 μM) (b), mustard oil (50 μM) (c), KCl (50 mM) (d) and
ionomycin (5 μM) (e) as indicated. Recordings in panel a are from cells
dissected from a wild type mouse, whereas the recording shown in b is
from a cell isolated from a TRPV1−/− mouse. A sub-population of
neurons isolated from wild type mice (a) responds to 50 μM 20:4-NAPE
application (gray trace). All these 20:4-NAPE-responding neurons also
respond to capsaicin (gray trace). However, not all capsaicin-responding
neurons respond to 20:4-NAPE application (black trace). While a sub-
population of neurons isolated from TRPV1−/− mice respond to mustard
oil (b), none of the cells respond either to 20:4-NAPE or capsaicin
Fig. 8 Sub-populations of cultured rat primary sensory neurons co-
express TRPV1 and enzymes implicated in Ca2+-insensitive anandamide
synthesis. Cultured rat PSN were incubated in antibodies raised against
TRPV1 (green) and ABHd4, GDE1, Inpp5 or PTPn22. For quantitative
data, please see Table 3. Scale bar=25 μm
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658 application (~38 pmol/5 min/mg protein) is well within the
659 range of 20:4-NAPE hydrolysis (up to ~40 pmol/min/mg
660 protein) measured in brain homogenates [20, 36, 37]. The
661 distribution of enzymes across PSN and non-neuronal cells
662 indicates that, while non-neuronal cells may produce some
663 anandamide, the greatest amount of this endocannabinoid/
664 endovanilloid is likely to be synthesised in PSN.
665 Calcium regulates the synthesis of anandamide mostly
666 through the NAPE-synthesising enzyme known as Ca2+-de-
667 pendent N-acyltransferase, which catalyses the formation of
668 20:4-NAPE [4, 8]. However, when this rate-limiting step in
669 anandamide and NAEA biosynthesis is bypassed, as in our
670 case, the only way for anandamide to be produced in a Ca2+-
671 sensitive manner is via NAPE-PLD action on 20:4-NAPE [4,
672 22, 23, 32, 36, 41–43] (Fig. 1). Indeed, in the absence of Ca2+,
673 NAPE-PLD activity is negligible even in the presence of the
674 substrate [42, 47], whereas increasing the [Ca2+]i alone results
675 in anandamide production [8, 44]. Although, application of
676 20:4-NAPE induces some increase in the [Ca2+]i, the finding
677 that removal of Ca2+ from the extracellular buffer does not
678 change the anandamide concentration in the superfusate sug-
679 gests that Ca2+ influx during 20:4-NAPE application is not
680 sufficiently high to induce NAPE-PLD activity. Hence, follow-
681 ing 20:4-NAPE application, at least the great majority of anan-
682 damide is synthesised by PSN by Ca2+-insensitive pathways.
683 Consequently, some of the Ca2+-insensitive anandamide-
684 synthesising enzymes present in the cultures prepared from
685 rat DRG form functional pathways, which may also include
686 the Ca2+-independent NAPE biosynthesising enzyme previous-
687 ly identified by Jin and colleagues [17]. However, the exact
688 identity of the pathway(s) is not known and attempts to dissect
689 them would produce ambiguous results at present because of
690 the unavailability of selective and specific blockers of the
691 enzymes.
692 Application of 20:4-NAPE results in cobalt-influx in a sub-
693 population of small diameter cultured PSN, the majority of
694 which express TRPV1 [6, 28, 31]. While the lowest concentra-
695 tion of 20:4-NAPE which induces a significant increase in the
696 number of cobalt-labelled neurons is 0.1 μM, the lowest con-
697 centration of 20:4-NAPE which results in a significant increase
698 in the anandamide content of the superfusate is 10 μM. We
699 have shown here, however, that PSN — similar to central
700 neurons [8] — retain the majority of anandamide. Hence, the
701 concentration of anandamide at the intracellular anandamide-
702 binding site of TRPV1 [18], is probably considerably higher
703 than that in the superfusate. This difference renders any direct
704 comparison between minimally effective concentrations of
705 20:4-NAPE at increasing the anandamide concentration in the
706 superfusate and at evoking Co2+ uptake very difficult.
707 In addition to inducing cobalt accumulation, application of
708 20:4-NAPE also increases the [Ca2+]i, and induces whole-cell
709 currents. All the cells which respond to 20:4-NAPE applica-
710 tion with increased [Ca2+]i, or inward currents, in control
711conditions, also respond to the archetypical TRPV1 agonist,
712capsaicin. Taken together, these data suggest that the 20:4-
713NAPE application-evoked excitatory effect is mediated
714through TRPV1 in PSN. Indeed, the TRPV1 antagonist
715capsazepine, which we applied at a concentration known to
716have little effect on other molecules than TRPV1 [11], signif-
717icantly reduces the proportion of neurons responding to
71820:4-NAPE application. However, the inhibitory effect of
719capsazepine might be different in species other than rat [46].
720Nevertheless, the finding that cultured PSN prepared from
721TRPV1−/− mouse DRG do not, whereas a sub-population of
722cultured PSN prepared from WT mouse DRG does, respond
723to 20:4-NAPE application provides evidence that, in PSN, the
72420:4-NAPE application-evoked excitatory effect is indeed
725mediated through TRPV1.
726Several findings indicate that the 20:4-NAPE application-
727induced excitatory effects are exerted indirectly, through anan-
728damide production. First, both the anandamide production,
729and the 20:4-NAPE application-induced cobalt accumulation,
730depend on the concentration of the substrate. Second, if 20:4-
731NAPE activated TRPV1 directly all capsaicin-sensitive neu-
732rons would be expected to respond. However, we found that
733only ~40% of capsaicin-responsive neurons exhibit responses
734to 20:4-NAPE application. Third, if 20:4-NAPE activated
735TRPV1 directly, a similar pattern of temperature-dependent
736change in the responsiveness of neurons to 20:4-NAPE and
737capsaicin is expected to occur. However, while application of
73820:4-NAPE, which induces responses in about a third of the
739neurons at 37 °C, fails to produce responses in any neurons at
740room temperature (Fig. S4a and b). At the same time, the
741proportion of capsaicin-responsive neurons is the same at
74237 °C and room temperature (Fig. 4b). Fourth, the lack of
743responsiveness to 20:4-NAPE at room temperature co-occurs
744with a 10-fold reduction in the anandamide content of the
745superfusate following the application of 20:4-NAPE to the
746cells. Fifth, direct TRPV1 activators, such as capsaicin and
747anandamide [18], activate TRPV1 with fast kinetics. Howev-
748er, the kinetics of 20:4-NAPE-induced responses are signifi-
749cantly slower than those of the capsaicin-evoked responses.
750Sixth, the amplitude of whole-cell currents produced by 20:4-
751NAPE application, which results in about 30 nM anandamide
752when the concentration is measured in the cells and
753superfusate together, is compatible with the amplitude of
754whole-cell currents evoked by 100 nM anandamide included
755into the recording electrode [12]. These findings collectively
756provide evidence that the 20:4-NAPE-evoked effects depend
757on enzyme activity and at least the majority, if not all, of the
75820:4-NAPE application-induced TRPV1-mediated excitation
759is produced indirectly, via the conversion of 20:4-NAPE to
760anandamide. The involvement of 20:4-NAPE-derived metab-
761olites other than anandamide is highly unlikely because thin
762layer chromatography shows the presence of no other lipids
763than anandamide and 20:4-NAPE in the superfusate (Fig. S5).
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764 The limited responsiveness of capsaicin-sensitive neurons to
765 20:4-NAPE may appear in contrast with the co-expression
766 pattern of TRPV1 and the four enzymes we examined in this
767 study. However, each of these four enzymes constitutes only a
768 member of specific enzymatic pathways (Fig. 1), none of which
769 is selective for the synthesis of anandamide [22, 23, 32, 36, 41,
770 43]. Due to the unknown molecular identity of some enzymes,
771 at present, it is impossible to establish the proportion of neurons
772 which express (or co-express) a complete anandamide-
773 synthesising pathway(s). Nevertheless, our findings suggest
774 that less than half of TRPV1-expressing neurons may express
775 pathways, which are able to produce anandamide in a Ca2+-
776 insensitive manner. These findings, together with the concen-
777 tration of anandamide in the superfusate, following 20:4-NAPE
778 application, being well below the minimum concentration of
779 exogenous anandamide needed for TRPV1 activation [1, 12,
780 14, 38, 51] also suggest that anandamide synthesised in a Ca2+-
781 insensitive manner, similar to anandamide produced through a
782 Ca2+-sensitive pathway [44], activates TRPV1 through auto-
783 crine signalling. Notably, the overall proportion of capsaicin-
784 responsive cells is increased from ~60 % to above 80 % when
785 20:4-NAPE is applied before capsaicin. Furthermore, more
786 dual-responsive than capsaicin-only-responsive neurons exhib-
787 it sustained/slowly inactivating capsaicin-induced increase in
788 the [Ca2+]i. Hence, the autocrine signalling by anandamide
789 synthesised in a Ca2+-insensitive manner by PSN seems to
790 have some sensitising effect on TRPV1-mediated responses,
791 which results in exhibiting such responses above the detection
792 threshold in neuronswhich do not produce detectable responses
793 to capsaicin in control conditions.
794 While exogenous anandamide induces a CB1 receptor-
795 mediated inhibition on TRPV1-mediated responses in PSN
796 [2, 14, 24, 27, 33], the selective and specific CB1 receptor
797 antagonist, rimonabant, reduces the proportion of neurons
798 responding to, and the amplitude of responses induced by,
799 20:4-NAPE application. These data may suggest that exoge-
800 nous anandamide, and anandamide produced from 20:4-
801 NAPE via Ca2+-insensitive pathways may exert their actions
802 through not completely overlapping mechanisms (i.e., while
803 exogenous anandamide induces a CB1 receptor-mediated in-
804 hibitory effect, endogenous anandamide does not induce such
805 effect). However, the effect of exogenous anandamide on
806 TRPV1 activity depends on its concentration and the avail-
807 ability of the CB1 receptor. Hence, exogenous anandamide
808 above 1 μM induces larger responses in TRPV1-CB1 receptor
809 co-expressing human embryonic kidney 293 cells than in such
810 cells when they express TRPV1 alone [16]. Consistently, the
811 exogenous anandamide-evoked excitatory effect is reduced by
812 rimonabant in cultured rat PSN [35]. Furthermore, like the
813 effect of anandamide on TRPV1, the effect of capsaicin is also
814 reduced when the CB1 receptor is not available either due to
815 the blocking CB1 receptor activity with rimonabant [35] or to
816 the deletion of the CB1 receptor [13]. In agreement with
817findings in CB1−/− mice [13], we found here that rimonabant
818reduces the amplitude of capsaicin-evoked responses, but not
819the proportion of neurons responding to capsaicin. Therefore,
820the inhibitory effect of rimonabant on the proportion of neuron
821responding to 20:4-NAPE by increased [Ca2+]i is consistent
822with the proposed constitutive sensitising action of the CB1
823receptor on TRPV1, which may occur under certain condi-
824tions [13, 16]. Hence, the effects of exogenous anandamide
825above 1 μM and the effects of endogenous anandamide
826synthesised from 50 μM 20:4-NAPE in a Ca2+-insensitive
827manner, at least as far as activating TRPV1 and not producing
828CB1 receptor-mediated inhibitory effects are concerned, are
829similar in PSN. Together these findings indicate that ananda-
830mide that is synthesised in a Ca2+-insensitive manner from
83150 μM 20:4-NAPE has an excitatory rather than an inhibitory
832effect in PSN.
833In conclusion, results of the present study show that: (a) a
834sub-population of PSN has at least one enzymatic pathway
835which synthesises anandamide from 20:4-NAPE in a Ca2+-
836insensitive manner; (b) the synthesis of anandamide from
837exogenous 20:4-NAPE primarily, if not exclusively, occurs
838via Ca2+-insensitive pathways; and (c) anandamide of PSN
839origin synthesised from 20:4-NAPE in a Ca2+-insensitive
840manner produces an autocrine TRPV1-mediated excitation,
841which may complement the previously reported excitatory
842effects on TRPV1 of anandamide synthesised in a Ca2+-sen-
843sitive manner in PSN [13]. The effect of anandamide of PSN
844origin together with the effects of exogenous anandamide on
845PSN [1, 12, 14, 24, 33] emphasises the high degree of flexi-
846bility of action of this important lipid mediator, and its multi-
847faceted role in controlling nociceptive processing [40]. There-
848fore, a better understanding of the expression and function of
849the anandamide-synthesising enzymes in PSN may allow us
850to control the activity of those cells, and hence develop more
851effective treatments of somato- and viscerosensory distur-
852bances outside the central nervous system.
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